company background image
CO

Global Cord Blood NYSE:CO Stock Report

Last Price

US$2.99

Market Cap

US$400.1m

7D

0%

1Y

-25.7%

Updated

01 Dec, 2022

Data

Company Financials
CO fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

CO Stock Overview

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China.

Global Cord Blood Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Global Cord Blood
Historical stock prices
Current Share PriceUS$2.99
52 Week HighUS$5.50
52 Week LowUS$2.03
Beta-0.042
1 Month Change0%
3 Month Change29.33%
1 Year Change-25.68%
3 Year Change-33.46%
5 Year Change-71.02%
Change since IPO-50.04%

Recent News & Updates

Global Cord Blood GAAP EPS of $0.14, revenue of $46.88M

Jul 05

Recent updates

Shareholder Returns

COUS HealthcareUS Market
7D0%3.2%1.5%
1Y-25.7%13.7%-14.8%

Return vs Industry: CO underperformed the US Healthcare industry which returned 13.7% over the past year.

Return vs Market: CO underperformed the US Market which returned -14.8% over the past year.

Price Volatility

Is CO's price volatile compared to industry and market?
CO volatility
CO Average Weekly Movementn/a
Healthcare Industry Average Movement8.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: Insufficient data to determine CO's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine CO's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,202Tina Zhenghttps://www.globalcordbloodcorp.com

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province.

Global Cord Blood Corporation Fundamentals Summary

How do Global Cord Blood's earnings and revenue compare to its market cap?
CO fundamental statistics
Market CapUS$400.08m
Earnings (TTM)US$71.14m
Revenue (TTM)US$176.53m

5.6x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CO income statement (TTM)
RevenueCN¥1.24b
Cost of RevenueCN¥183.31m
Gross ProfitCN¥1.06b
Other ExpensesCN¥558.88m
EarningsCN¥501.07m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)3.74
Gross Margin85.26%
Net Profit Margin40.30%
Debt/Equity Ratio0%

How did CO perform over the long term?

See historical performance and comparison